Related Experiment Video
Updated: May 22, 2026

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
Elevated serum levels of Vitamin D in infants with urolithiasis
Mohammad Hossein Fallahzadeh1, Javad Zare, Ghamar Hosseini Al-Hashemi
1Shiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Insights
Infants with urolithiasis had significantly higher serum vitamin D levels than controls. This suggests high vitamin D may contribute to infant kidney stones, especially in those with hypercalcemia.
Area of Science:
- Pediatric Nephrology
- Endocrinology
- Urology
Background:
- The causes of infant urolithiasis are not well understood.
- This study explores a potential link between vitamin D levels and kidney stone formation in infants.
Purpose of the Study:
- To investigate if infants with urolithiasis have elevated serum vitamin D levels compared to healthy infants.
- To identify potential risk factors for kidney stone development in infants.
Main Methods:
- A case-control study involving 36 infants with urolithiasis and 36 matched controls.
- Analysis of serum and urine samples for various biochemical markers, including 25-hydroxyvitamin D3, calcium, and citrate.
Main Results:
- Infants with urolithiasis showed significantly higher serum 25-hydroxyvitamin D3 levels (33.85 ± 14.78 ng/mL) compared to controls (18.26 ± 7.43 ng/mL).
- Twenty-five percent of infants with urolithiasis had hypercalcemia, and 16.7% had hypocitraturia.
- Nineteen infants (52.8%) with urolithiasis presented with at least one metabolic abnormality.
Conclusions:
- Elevated serum vitamin D may be a significant factor in infant urolithiasis, particularly in cases involving hypercalcemia.
- Routine assessment of vitamin D levels is recommended for infants diagnosed with kidney stones.
Introduction:
The pathophysiology of urolithiasis in infancy is not well known. The aim of this study was to investigate whether infants with urolithiasis have higher serum levels of vitamin D, as a possible risk factor for urolithiasis, compared to infants without urinary calculi.
Materials And Methods:
In this case-control study, 36 infants with urolithiasis (age range, 2.5 to 24 months) were enrolled as well as 36 age- and sex-matched infants without urolithiasis. Random urine samples were tested for calcium, phosphorous, oxalate, citrate, uric acid, sodium, potassium, magnesium, and creatinine levels, and also nitroprusside test was done on the samples. Serum levels of potassium, urea nitrogen, creatinine, 25-hydroxyvitamin D3, parathyroid hormone, calcium, phosphorous, and uric acid were measured in all of the infants with urolithiasis. Serum levels of 25-hydroxyvitamin D3 were also measured in the control group.
Results:
Serum levels of 25-hydroxyvitamin D3 were significantly higher in the infants with urolithiasis than in the controls (33.85 ± 14.78 ng/mL versus 18.26 ± 7.43 ng/mL, P < .001). Nine infants in the urolithiasis group (25%) were found to have hypercalcemia; 3 of these cases also had hypervitaminosis D. Hypercalciuria was detected in 10 infants with urolithiasis (27.8%), hypocitraturia in 6 (16.7%), hypomagnesiuria in 3 (8.3%), and hyperoxaluria in 1 (2.8%). Nineteen infants with urolithiasis had at least one metabolic disorder.
Conclusions:
High serum levels of vitamin D may play an important role in the pathogenesis of urolithiasis in infants with hypercalcemia. We recommend evaluation of vitamin D levels in these infants.
Related Concept Videos
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi III: Medical Management
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Urinary Tract Calculi I: Introduction
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Serum Studies: Renal Function Tests
